Day 7 blastocysts can lead to healthy pregnancies, but they do carry lower success rates than embryos that reach the blastocyst stage on day 5 or day 6. If your clinic told you that your only viable embryo is a day 7 blastocyst, that embryo is still worth considering, especially if genetic testing confirms it’s chromosomally normal.
Why Some Embryos Take Until Day 7
In a typical IVF cycle, embryos are cultured in the lab and monitored as they divide and grow. Most reach the blastocyst stage (a fluid-filled ball of about 100 cells) by day 5 or day 6. Some embryos develop more slowly. When researchers tracked day 7 blastocysts backward, 68% were still at or before the compacted cell-ball stage on day 5, and 12% hadn’t progressed past that stage even by day 6. Only a small fraction (about 4%) had already formed a recognizable blastocyst by day 5 but were graded too low in quality to freeze at that point.
The reasons for this delay aren’t fully understood. It may reflect reduced cellular energy, a slower-dividing cell line, or simply natural variation in developmental timing. Cycles using frozen eggs tend to produce more day 7 blastocysts, as do cycles where embryo development is generally sluggish across the board. About 8% of embryos in one study showed no visible change between day 5 and day 6, suggesting a temporary developmental pause before resuming growth.
Chromosomal Normality Rates
One of the biggest concerns with day 7 blastocysts is a higher rate of chromosomal abnormalities. When embryos are tested through preimplantation genetic testing (PGT-A), roughly 30% to 37% of day 7 blastocysts come back chromosomally normal (euploid). That’s meaningfully lower than the euploidy rates for day 5 and day 6 embryos, which typically range from 50% to 60% depending on the patient’s age.
This means that if you have a day 7 blastocyst and it hasn’t been genetically tested, the odds of it being chromosomally normal are lower from the start. However, if your embryo has already been tested and confirmed euploid, that particular concern is off the table. The embryo has passed the same genetic screen that any day 5 or day 6 embryo would.
Pregnancy and Live Birth Rates
When a genetically normal day 7 blastocyst is transferred, live birth rates in published studies range from about 21% to 46%. That’s a wide range, and it reflects differences in patient populations, lab protocols, and study sizes. For comparison, euploid day 5 embryos typically achieve live birth rates in the range of 50% to 65%.
One key study looked at sustained implantation rates (meaning the embryo implanted and continued developing) after transferring a single euploid embryo. Day 7 embryos achieved a 52.6% sustained implantation rate, compared to slightly higher rates for day 5 and day 6 embryos. The difference was not statistically significant, meaning the study couldn’t confirm that day 7 embryos truly perform worse once they’re confirmed euploid. But the sample sizes were small, so the true gap may become clearer with more data.
Miscarriage Risk Is Higher
This is the most important number to be aware of. In one large analysis, the miscarriage rate for day 7 blastocyst transfers was 47.4%, compared to 18.2% for day 5 and 20.6% for day 6 transfers. That’s roughly two and a half times the miscarriage rate.
Researchers have proposed several explanations. The extended time in culture may cause some deterioration of the outer cell layer (the part that becomes the placenta), which could impair the embryo’s ability to implant securely and sustain a pregnancy. There may also be a timing mismatch: the uterine lining is optimally receptive during a specific window, and transferring a slower-developing embryo on the standard schedule could mean the lining and the embryo are slightly out of sync. Some clinics are exploring whether adjusting the hormonal support protocol for day 7 transfers might improve outcomes, though this hasn’t been standardized yet.
What Happens to Babies Born From Day 7 Embryos
For pregnancies that do progress to delivery, the reassuring news is that babies born from day 7 blastocysts appear healthy. One study comparing neonatal outcomes found no significant differences in rates of preterm birth, low birth weight, or being small for gestational age when day 7 babies were compared to those from day 5 or day 6 embryos. Day 7 blastocyst babies actually had slightly higher birth weights on average and a higher incidence of being very large for gestational age, though the clinical significance of that finding is unclear. The key takeaway: once a day 7 pregnancy reaches full term, the baby’s health outcomes look comparable to those from earlier-developing embryos.
Should You Transfer a Day 7 Blastocyst?
The decision depends heavily on your situation. If a day 7 blastocyst is your only embryo, transferring it gives you a real, if reduced, chance at pregnancy. The alternative is having no embryo to transfer at all, which means starting another retrieval cycle. Many clinics now culture embryos through day 7 specifically because discarding slow developers on day 6 means losing embryos that could have led to live births.
Genetic testing makes a significant difference in how to think about a day 7 embryo. An untested day 7 blastocyst carries roughly a 70% chance of being chromosomally abnormal, which substantially lowers the odds of success. A tested, euploid day 7 blastocyst narrows the gap with day 5 and day 6 embryos considerably, though the higher miscarriage rate suggests that chromosomal status alone doesn’t explain all of the reduced potential.
If you have both day 5 or day 6 embryos and a day 7 embryo available, your clinic will almost certainly prioritize the earlier-developing ones for transfer. The day 7 embryo remains a viable backup. For patients with limited embryos or those in cycles where development was broadly delayed, keeping and potentially transferring a day 7 blastocyst is a reasonable strategy that many reproductive endocrinologists now support.